Corpus Intelligence IC Memo — DELAWARE COUNTY MEMORIAL HOSPITAL 2026-04-26 11:18 UTC
IC Memo — DELAWARE COUNTY MEMORIAL HOSPITAL
Investment Committee Memorandum | IA | 25 beds | Grade C | EBITDA uplift $4.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

DELAWARE COUNTY MEMORIAL HOSPITAL

CCN 161343 | DELAWARE, IA | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

DELAWARE COUNTY MEMORIAL HOSPITAL is a 25-bed suburban community hospital in DELAWARE, IA with $66.5M in net patient revenue and a -1.2% operating margin. The hospital serves a payer mix of 31.8% Medicare, 0.5% Medicaid, and 67.7% commercial.

Thesis: Turnaround. Our ML models identify $4.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -1.2% to 6.2% (+736bps).

Net Revenue HCRIS$66.5M
Current EBITDA COMPUTED$-773K
Operating Margin COMPUTED-1.2%
Occupancy HCRIS32.4%
Revenue / Bed COMPUTED$2.7M
Net-to-Gross HCRIS52.3%
Distress Probability ML51.6%

2. Market Context & Competitive Position

124
IA Hospitals
-8.2%
State Median Margin
93
Comparable Hospitals

IA has 124 Medicare-certified hospitals with a median operating margin of -8.2%. The target's margin of -1.2% places it above the state median. Among 93 size-comparable peers (12-50 beds), the median margin is -8.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 93 hospitals in the comp set.

HospitalStateBedsRevenueMargin
DELAWARE COUNTY MEMORIAL HOSPI (Target)IA25$66.5M-1.2%
TRINITY REGIONAL MEDICAL CENTEIA44$140.4M-6.8%
PELLA REGIONAL HEALTH CENTERIA25$108.8M-16.6%
SPENCER MUNICIPAL HOSPITALIA49$108.7M-10.3%
GREATER REGIONAL MEDICAL CENTEIA25$89.4M-4.4%
ST. ANTHONY REGIONAL HOSPITALIA49$84.0M-21.0%
WINNESHIEK MEDICAL CENTERIA25$77.6M-0.1%
IOWA SPECIALTY HOSPITAL - CLARIA25$77.3M0.2%
MAHASKA HEALTH PARTNERSHIPIA25$75.6M-3.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.4M+210bp18mo
Cost to Collect4.5%2.5%$1.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$809K+122bp9mo
Clean Claim Rate88.0%96.0%$43K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.4M
Cost to Collect
$1.3M
Denial Rate Reduction
$1.3M
A/R Days Reduction
$809K
Clean Claim Rate
$43K
Total EBITDA Uplift$4.9M
Current EBITDA$-773K
+ RCM Uplift+$4.9M
Pro Forma EBITDA$4.1M
Current Margin-1.2%
Pro Forma Margin6.2%
WC Released (1x)$2.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.2M$43.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.2M$47.9M0.00x-100.0%
Bull Case9.0x11.0x$-1.1M$63.6M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.1M$69.1M0.00x-100.0%
Bear Case11.0x10.0x$-1.3M$19.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.3M$21.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 32.4%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 51.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 93 hospitals with 12-50 beds
  • Same-state prioritization (n=94)
  • Comp margins: P25=-14.6% / P50=-8.4% / P75=-3.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.